-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Upgrades Theriva Biologics to Buy, Announces $1 Price Target

Benzinga·03/31/2026 20:57:46
Listen to the news
Maxim Group analyst Jason McCarthy upgrades Theriva Biologics (AMEX:TOVX) from Hold to Buy and announces $1 price target.